These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30205907)

  • 1. Predictors of Clostridium difficile infection and predictive impact of probiotic use in a diverse hospital-wide cohort.
    Carvour ML; Wilder SL; Ryan KL; Walraven C; Qeadan F; Brett M; Page K
    Am J Infect Control; 2019 Jan; 47(1):2-8. PubMed ID: 30205907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microbial Preparations (Probiotics) for the Prevention of Clostridium difficile Infection in Adults and Children: An Individual Patient Data Meta-analysis of 6,851 Participants.
    Johnston BC; Lytvyn L; Lo CK; Allen SJ; Wang D; Szajewska H; Miller M; Ehrhardt S; Sampalis J; Duman DG; Pozzoni P; Colli A; Lönnermark E; Selinger CP; Wong S; Plummer S; Hickson M; Pancheva R; Hirsch S; Klarin B; Goldenberg JZ; Wang L; Mbuagbaw L; Foster G; Maw A; Sadeghirad B; Thabane L; Mertz D
    Infect Control Hosp Epidemiol; 2018 Jul; 39(7):771-781. PubMed ID: 29695312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics.
    Tilton CS; Johnson SW
    Am J Infect Control; 2019 Mar; 47(3):280-284. PubMed ID: 30318399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation of Global Strategies to Prevent Hospital-Onset Clostridium difficile Infection: Targeting Proton Pump Inhibitors and Probiotics.
    Lewis PO; Lundberg TS; Tharp JL; Runnels CW
    Ann Pharmacother; 2017 Oct; 51(10):848-854. PubMed ID: 28821215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
    Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
    Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Institutional review of the implementation and use of a Clostridium difficile infection bundle and probiotics in adult trauma patients.
    Bommiasamy AK; Connelly C; Moren A; Dodgion C; Bestall K; Cline A; Martindale RG; Schreiber MA; Kiraly LN
    Am J Surg; 2018 May; 215(5):825-830. PubMed ID: 29490870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the epidemiology of community- and hospital-associated Clostridium difficile infections in Northern Ireland, 2012-2016: a population data linkage and case-case study.
    Maisa A; Ross G; Verlander NQ; Fairley D; Bradley DT; Patterson L
    Epidemiol Infect; 2019 Jan; 147():e141. PubMed ID: 30869054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton Pump Inhibitors Do Not Increase Risk for Clostridium difficile Infection in the Intensive Care Unit.
    Faleck DM; Salmasian H; Furuya EY; Larson EL; Abrams JA; Freedberg DE
    Am J Gastroenterol; 2016 Nov; 111(11):1641-1648. PubMed ID: 27575714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Clostridium difficile infection in Portugal: Experience at a tertiary care hospital.
    Sintra S; Taveira F; Canha C; Carvalho A; Simão A
    Eur J Intern Med; 2019 Feb; 60():e11-e13. PubMed ID: 30343987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of antibiotics and case exposure on hospital-acquired Clostridium difficile infection independent of illness severity.
    Forster AJ; Daneman N; van Walraven C
    J Hosp Infect; 2017 Apr; 95(4):400-409. PubMed ID: 27825674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Saccharomyces boulardii Primary Prevention on Risk of Hospital-onset Clostridioides difficile Infection in Hospitalized Patients Administered Antibiotics Frequently Associated With C. difficile Infection.
    Wombwell E; Patterson ME; Bransteitter B; Gillen LR
    Clin Infect Dis; 2021 Nov; 73(9):e2512-e2518. PubMed ID: 32575126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the risk and disease burden of Clostridium difficile infection among patients with hospital-acquired pneumonia at a University Hospital in Central China.
    Li C; Duan J; Liu S; Meng X; Fu C; Zeng C; Wu A
    Infection; 2017 Oct; 45(5):621-628. PubMed ID: 28497295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Clostridium difficile infection in hospitalized patients receiving metronidazole for a non-C difficile infection.
    Rodriguez S; Hernandez MB; Tarchini G; Zaleski M; Vatanchi M; Cardona L; Castro-Pavia F; Schneider A
    Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1856-61. PubMed ID: 24681079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Clostridium difficile Infection with Systemic Antimicrobial Therapy Following Successful Fecal Microbiota Transplant: Should We Recommend Anti-Clostridium difficile Antibiotic Prophylaxis?
    Allegretti JR; Kao D; Phelps E; Roach B; Smith J; Ganapini VC; Kassam Z; Xu H; Fischer M
    Dig Dis Sci; 2019 Jun; 64(6):1668-1671. PubMed ID: 30632052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with Clostridium difficile infection: A nested case-control study in a three year prospective cohort.
    Khanafer N; Vanhems P; Barbut F; Luxemburger C; ; Demont C; Hulin M; Dauwalder O; Vandenesch F; ; Argaud L; Badet L; Barth X; Bertrand M; Burillon C; Chapurlat R; Chuzeville M; Comte B; Disant F; Fessy MH; Gouillat C; Juillard L; Lermusiaux P; Monneuse O; Morelon E; Ninet J; Ponchon T; Poulet E; Rimmele T; Tazarourte K
    Anaerobe; 2017 Apr; 44():117-123. PubMed ID: 28279859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinguishing community-associated from hospital-associated Clostridium difficile infections in children: implications for public health surveillance.
    Tschudin-Sutter S; Tamma PD; Naegeli AN; Speck KA; Milstone AM; Perl TM
    Clin Infect Dis; 2013 Dec; 57(12):1665-72. PubMed ID: 24046303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Community-associated Clostridium difficile infection among older people in Tayside, Scotland, is associated with antibiotic exposure and care home residence: cohort study with nested case-control.
    Marwick CA; Yu N; Lockhart MC; McGuigan CC; Wiuff C; Davey PG; Donnan PT
    J Antimicrob Chemother; 2013 Dec; 68(12):2927-33. PubMed ID: 23825381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timely Use of Probiotics in Hospitalized Adults Prevents Clostridium difficile Infection: A Systematic Review With Meta-Regression Analysis.
    Shen NT; Maw A; Tmanova LL; Pino A; Ancy K; Crawford CV; Simon MS; Evans AT
    Gastroenterology; 2017 Jun; 152(8):1889-1900.e9. PubMed ID: 28192108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology and risk factors for Clostridium difficile infection in children.
    Sandora TJ; Fung M; Flaherty K; Helsing L; Scanlon P; Potter-Bynoe G; Gidengil CA; Lee GM
    Pediatr Infect Dis J; 2011 Jul; 30(7):580-4. PubMed ID: 21233782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.